Summarized by Masters of Longevity from Longevity Technology.
Kailera will present Phase 3 trial designs and real-world obesity analyses at ObesityWeek.
Key Takeaways
- Kailera is presenting KaiNETIC-1 and KaiNETIC-2 Phase 3 designs.
- The company is presenting KaiNETIC-3 plus a REFLECT methods analysis.
- Ribupatide has been studied in over three thousand trial participants.
